Form 4: Health Catalyst CFO Reports Stock Transaction
Insider Transaction (Form 4)
Jason Alger, Chief Financial Officer of Health Catalyst, Inc., reported a transaction in 17,973 shares of common stock on September 1, 2026.
Summary
- Tax/exercise-price withholding: disposed of 17,973 Common Stock at $1.70 ($30,619) on September 1, 2026; holds 704,867 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jason Alger — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Tax/exercise-price withholding | Common Stock | 17,973 | $2 | $30.6K | 704,867 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Tax/exercise-price withholding (17,973 shares) |
Keywords
insider transaction, Form 4, HCAT, Health Catalyst, Inc., neutral, Jason Alger
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.